# OnCo record who-essential-medicines (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/who-essential-medicines/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "who-essential-medicines" ;
  schema:name "WHO Essential Medicines List for cancer"@en ;
  schema:description "The World Health Organization's list of medicines every health system should provide, which now includes about 60 cancer drugs from cyclophosphamide and cisplatin to trastuzumab, imatinib and PD-1 inhibitors, guiding procurement and pricing in lower-income countries."@en ;
  schema:url <https://onco.cc/terms/who-essential-medicines/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/WHO_Model_List_of_Essential_Medicines> ;
  schema:citation <https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines/essential-medicines-lists> ;
  onco:tag "gap-fill", "policy", "global" ;
  onco:related <https://onco.cc/technologies/global-oncology-access/>, <https://onco.cc/terms/drug-price-transparency/>, <https://onco.cc/terms/biosimilar/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/imatinib/>, <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/terms/trips-doha/>, <https://onco.cc/terms/nexavar-compulsory-licence/>, <https://onco.cc/terms/china-vbp-nrdl/>, <https://onco.cc/terms/novartis-glivec-ruling/> .